A Short History of Thrombosis and Hemostasis: Part II (40th Year Celebratory Issue)

Emmanuel J. Favaloro

doi:10.1055/s-0034-1395164

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2014; 40(08): 826-830
DOI: 10.1055/s-0034-1395164

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

A Short History of Thrombosis and Hemostasis: Part II (40th Year Celebratory Issue)

Autor*innen

Emmanuel J. Favaloro

¹Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, Australia

Abstract

Volltext

Referenzen

References
1 Schiff D. Eulogy. Eberhard Mammen, M.D. 1930–2008. Semin Thromb Hemost 2008; 34: 305
2 Prasad A, Kwaan HC. In memoriam: a tribute to Eberhard F Mammen, M.D. (1930–2008). Semin Thromb Hemost 2008; 34: 697-698
3 Fareed J, Walenga JM, Hoppensteadt DA, Bick RL, Messmore HL. Dr Eberhard F Mammen remembered: a great clinician-scientist, mentor, and friend. Semin Thromb Hemost 2008; 34: 128-130
4 Favaloro EJ. A tribute to Eberhard F. Mammen, M.D. (1930-2008). Semin Thromb Hemost 2008; 34 (8) 703-707
5 Favaloro EJ. A short history of thrombosis and hemostasis: part I (40th year celebratory issue). Semin Thromb Hemost 2014; 40 (5) 521-525
6 Harenberg J, Casu B, Krämer R, Torri G, Naggi A, Krämer S. Glycosaminoglycans: anticoagulant and nonanticoagulant actions: a short history of symposia held at Villa Vigoni. Semin Thromb Hemost 2014; 40 (8) 831-836
7 Lassila R, Jouppila A. Mast-cell derived heparin proteoglycans as a model for a local antithrombotic. Semin Thromb Hemost 2014; 40 (8) 837-844
8 Gatt A, Chen D, Pruthi RK , et al. From vitamin k antagonists to liver international normalized ratio: a historical journey and critical perspective. Semin Thromb Hemost 2014; 40 (8) 845-851
9 Suryanarayan D, Schulman S. When the rubber meets the road: adherence and persistence with non–vitamin K antagonist oral anticoagulants and old oral anticoagulants in the real world—a problem or myth?. Semin Thromb Hemost 2014; 40 (8) 852-859
10 Husted S, de Caterina R, Andreotti F , et al; ESC Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel. Thromb Haemost 2014; 111 (5) 781-782
11 Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): Is there consensus?. Clin Chem Lab Med 2014; ; DOI: 10.1515/cclm-2014-0767
12 Gurewich V. Guidelines for the management of anticoagulant therapy. Semin Thromb Hemost 1976; 2 (3) 176-196
13 Pengo V, Bison E, Denas G, Jose SP, Bracco A, Banzato A. The paradox of the Lupus anticoagulant: history and perspectives. Semin Thromb Hemost 2014; 40 (8) 860-865
14 Favaloro EJ, Wong RC. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology 2014; 46 (6) 481-495
15 Triplett DA. Laboratory diagnosis of lupus anticoagulants. Semin Thromb Hemost 1990; 16 (2) 182-192
16 Douglas A. Triplett Obituary. Available at: http://www.legacy.com/obituaries/jconline/obituary.aspx?pid=164404186 . Accessed August 30, 2014
17 Wada H, Matsumoto M, Yamashita Y. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Thromb Hemost 2014; 40 (8) 866-873
18 Favaloro EJ. Hemolytic uremic syndrome. Preface. Semin Thromb Hemost 2010; 36 (6) 573-574
19 Riedl M, Orth-Höller D, Würzner R. An update on the thrombotic microangiopathies hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemost 2014; 40 (4) 413-415
20 Levi M, van der Poll T. A short contemporary history of disseminated intravascular coagulation. Semin Thromb Hemost 2014; 40 (8) 874-880
21 Bick RL. Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemost 1988; 14 (4) 299-338
22 Franchini M, Lippi G, Favaloro EJ. Dedication. Rodger L. Bick, M.D., Ph.D., FACP (1943–2008). Semin Thromb Hemost 2009; 35: 255-256
23 Fareed J, Walenga J, Messmore H, Baker W, Bick M. In memoriam: Rodger L. Bick, MD, PhD, FACP—a wonderful friend, great clinician, and brilliant educator. Clin Appl Thromb Hemost 2009; 15: 5-7
24 Ellery PER, Adams MJ. Tissue factor pathway inhibitor: then and now. Semin Thromb Hemost 2014; 40 (8) 881-886
25 de Maat S, de Groot PG, Maas C. Contact system activation on endothelial cells. Semin Thromb Hemost 2014; 40 (8) 887-894
26 Oldenburg J, Pezeshkpoor B, Pavlova A. A historic review on genetic analysis in hemophilia A. Semin Thromb Hemost 2014; 40 (8) 895-902